Lazard Asset Management’s Guardant Health GH Stock Holding History

Lazard Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45,000	Closed	-$4.16M	–	2019
2026 Q1	$4.16M	Sell	45,000 -50,000	-53%	-$5.02M	0.01%	610
2025 Q4	$9.7M	Buy	+95,000	New	+$8.5M	0.02%	419

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Lazard Asset Management's GH Position: Q2 2026 in Review

Lazard Asset Management reduced its Guardant Health (GH) stake by 13% in Q2 2026, selling an estimated $354K and leaving 21,165 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Lazard Asset Management first reported a position in GH in Q2 2020 and has held it in 24 quarters since. The position peaked at $11.8M in Q3 2022. 599 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Lazard Asset Management held 21,165 shares of Guardant Health worth $3.18M as of Q2 2026.
Lazard Asset Management sold 3,254 Guardant Health shares in Q2 2026, an estimated $354K.
Guardant Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #778 holding.
Lazard Asset Management first reported a position in Guardant Health in Q2 2020 and has held it in 24 quarters since.
Lazard Asset Management's Guardant Health position peaked at $11.8M in Q3 2022.
599 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.